This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ZADIK, Z. Articles by KOWARSKI, A. Search for Related Content PubMed PubMed Citation Articles by ZADIK, Z. Articles by KOWARSKI, A.

Assessment of Growth Hormone Secretion in Normal Stature Children Using 24-Hour Integrated Concentration of GH and Pharmacological Stimulation

Pediatric Endocrine Unit (Z.Z.), Kaplan Hospital Rehovot, Israel;
Department of Pediatrics (S.A.C., A.A.K.), University of Maryland School of Medicine Baltimore, Maryland 21201

Address correspondence and requests for reprints to: Zvi Zadik, M.D., Pediatric Endocrine Unit, Kaplan Hospital, Rehovot, 76100 Israel.

The integrated concentration of serum GH (ICGH) is used for the assessment of spontaneous GH secretion. In order to use the IC-GH as a diagnostic tool a normative reference range needs to be established. We determined the IC-GH by continuous blood withdrawal in 119 children of normal height, weight and growth rate. Although the mean IC-GH increased with pubertal status, 4.4 ± 1.2 µg/L at Tanner I (n = 36), 5.5 ± 2.1 µg/L at Tanner II-III (n = 43), and 5.8 ± 1.6 at Tanner IV-V (n = 40) (P < 0.03), there was a considerable overlap of individual IC-GH levels between the pubertal groups. Gender affected the mean IC-GH level slightly, but not the range. Although the mean IC-GH of girls tended to be higher than that of boys this difference was not statistically significant. Ninety five percent of the IC-GH values were above the 3.2 µg/L level.

The response to pharmacological stimulation (clonidine, insulin, or arginine) was also evaluated in 68 of the subjects. The peak GH response to pharmacological stimulation (µg/L) with clonidine 21.0 ± 10.7 (n = 66) was significantly higher than to either arginine 13.1 ± 6.1 (n = 23) or insulin 14.2 ± 6.3 (n = 19) (P < 0.01). The peak response to clonidine increased significantly with pubertal status (P < 0.001) and there was an interactive effect of gender and pubertal stage where the GH response of prepubertal boys exceeded that of prepubertal girls but the response of pubertal girls exceeded that of pubertal boys (P < 0.02). The peak stimulated GH levels was correlated with ICGH in this subgroup r = 0.52, P < 0.0001).

This study provides a large normative data base for IC-GH and the GH provocative tests in normally growing children of varying pubertal status.

Received October 23, 1989.

This article has been cited by other articles:

				M. Misra, J. Cord, R. Prabhakaran, K. K. Miller, and A. Klibanski Growth Hormone Suppression after an Oral Glucose Load in Children J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4623 - 4629. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				R Ayling More guidance on growth hormone deficiency J. Clin. Pathol., February 1, 2004; 57(2): 123 - 125. [Full Text] [PDF]

				M. J. Abuzzahab, A. Schneider, A. Goddard, F. Grigorescu, C. Lautier, E. Keller, W. Kiess, J. Klammt, J. Kratzsch, D. Osgood, et al. IGF-I Receptor Mutations Resulting in Intrauterine and Postnatal Growth Retardation N. Engl. J. Med., December 4, 2003; 349(23): 2211 - 2222. [Abstract] [Full Text] [PDF]

				N. Weintrob, D. Cohen, Y. Klipper-Aurbach, Z. Zadik, and Z. Dickerman Decreased Growth During Therapy With Selective Serotonin Reuptake Inhibitors Arch Pediatr Adolesc Med, July 1, 2002; 156(7): 696 - 701. [Abstract] [Full Text] [PDF]

				M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al. Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry Pediatrics, April 1, 2001; 107(4): 744 - 754. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, and A. D. Rogol Gender and Sexual Maturation-Dependent Contrasts in the Neuroregulation of Growth Hormone Secretion in Prepubertal and Late Adolescent Males and Females--A General Clinical Research Center-Based Study J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2385 - 2394. [Abstract] [Full Text]

				S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan The Diagnosis of Growth Hormone Deficiency in Children and Adults Endocr. Rev., April 1, 1998; 19(2): 203 - 223. [Abstract] [Full Text]